These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 23796241)

  • 1. Exposure ethics: does HIV pre-exposure prophylaxis raise ethical problems for the health care provider and policy maker?
    Venter F; Allais L; Richter M
    Bioethics; 2014 Jul; 28(6):269-74. PubMed ID: 23796241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical Implications of Social Stigma Associated with the Promotion and Use of Pre-Exposure Prophylaxis for HIV Prevention.
    Herron PD
    LGBT Health; 2016 Apr; 3(2):103-8. PubMed ID: 26859191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cultural conundrums: the ethics of epidemiology and the problems of population in implementing pre-exposure prophylaxis.
    Fiereck K
    Dev World Bioeth; 2015 Apr; 15(1):27-39. PubMed ID: 24373050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical public health issues for the use of informal PrEP.
    Brisson J
    Glob Public Health; 2018 Oct; 13(10):1382-1387. PubMed ID: 28868979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ensuring the Ethical Implementation of the New World Health Organization Pre-Exposure Prophylaxis Recommendations for Men Who Have Sex with Men.
    Arora KS; Streed CG
    LGBT Health; 2015 Mar; 2(1):11-3. PubMed ID: 26790012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethics of ARV based prevention: treatment-as-prevention and PrEP.
    Haire B; Kaldor JM
    Dev World Bioeth; 2013 Aug; 13(2):63-9. PubMed ID: 23594312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge is Power! Increased Provider Knowledge Scores Regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Intent to Prescribe PrEP.
    Blumenthal J; Jain S; Krakower D; Sun X; Young J; Mayer K; Haubrich R;
    AIDS Behav; 2015 May; 19(5):802-10. PubMed ID: 25616837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PrEP: controversy, agency and ownership.
    Cairns GP; Race K; Goicochea P
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21120. PubMed ID: 27760689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ethical Relevance of "Alternatives" in Health Care Priority Setting - The Case of Preexposure Prophylaxis (PrEP) of HIV.
    Gustavsson E; Björk J
    Yale J Biol Med; 2022 Sep; 95(3):359-365. PubMed ID: 36187410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vital Signs: Increased Medicaid Prescriptions for Preexposure Prophylaxis Against HIV infection--New York, 2012-2015.
    Laufer FN; O'Connell DA; Feldman I; ; Zucker HA
    MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(46):1296-301. PubMed ID: 26606257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The performative function of expectations in translating treatment to prevention: the case of HIV pre-exposure prophylaxis, or PrEP.
    Rosengarten M; Michael M
    Soc Sci Med; 2009 Oct; 69(7):1049-55. PubMed ID: 19695756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'PrEP is not ready for our community, and our community is not ready for PrEP': pre-exposure prophylaxis for HIV for people who inject drugs and limits to the HIV prevention response.
    Guise A; Albers ER; Strathdee SA
    Addiction; 2017 Apr; 112(4):572-578. PubMed ID: 27273843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond "getting drugs into bodies": social science perspectives on pre-exposure prophylaxis for HIV.
    Auerbach JD; Hoppe TA
    J Int AIDS Soc; 2015; 18(4 Suppl 3):19983. PubMed ID: 26198346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Awareness of, usage of and willingness to use HIV pre-exposure prophylaxis among men in downtown Toronto, Canada.
    Leonardi M; Lee E; Tan DH
    Int J STD AIDS; 2011 Dec; 22(12):738-41. PubMed ID: 22174057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putting the NHS England on trial: uncertainty-as-power, evidence and the controversy of PrEP in England.
    Nagington M; Sandset T
    Med Humanit; 2020 Sep; 46(3):176-179. PubMed ID: 32054770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Turning the tide against AIDS by preventing new HIV infections initial experience with Minnesota's first PrEP clinic.
    Eccles-Radtke C; Henry K
    Minn Med; 2015 Jan; 98(1):45-8. PubMed ID: 25665269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparing for pre-exposure prophylaxis: perceptions and readiness of Canadian pharmacists for the implementation of HIV pre-exposure prophylaxis.
    Yoong D; Naccarato M; Sharma M; Wilton J; Senn H; Tan DH
    Int J STD AIDS; 2016 Jul; 27(8):608-16. PubMed ID: 26025254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State-Level Discrimination Policies And HIV Pre-Exposure Prophylaxis Adoption Efforts In The US.
    Bonett S; Meanley S; Elsesser S; Bauermeister J
    Health Aff (Millwood); 2020 Sep; 39(9):1575-1582. PubMed ID: 32897779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethics and HIV prevention research: An analysis of the early tenofovir PrEP trial in Nigeria.
    Peterson K; Folayan MO
    Bioethics; 2019 Jan; 33(1):35-42. PubMed ID: 30198594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparing for PrEP.
    Lacor P
    Eur J Contracept Reprod Health Care; 2012 Dec; 17(6):482-6. PubMed ID: 23113873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.